Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 40% ± 18% | |
| ciliated cell | 5 studies | 38% ± 6% | |
| hematopoietic precursor cell | 3 studies | 24% ± 5% | |
| endothelial cell | 3 studies | 27% ± 8% | |
| dendritic cell | 3 studies | 26% ± 4% | |
| goblet cell | 3 studies | 21% ± 5% | |
| basal cell | 3 studies | 33% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 100% | 1900.72 | 1809 / 1809 | 100% | 66.38 | 472 / 472 |
| uterus | 100% | 951.99 | 170 / 170 | 100% | 96.78 | 459 / 459 |
| thymus | 100% | 961.08 | 653 / 653 | 100% | 49.69 | 604 / 605 |
| ovary | 100% | 678.03 | 180 / 180 | 100% | 43.57 | 429 / 430 |
| adrenal gland | 100% | 929.34 | 258 / 258 | 100% | 38.99 | 229 / 230 |
| brain | 100% | 1106.63 | 2630 / 2642 | 100% | 55.53 | 705 / 705 |
| esophagus | 100% | 1115.76 | 1445 / 1445 | 99% | 36.75 | 182 / 183 |
| breast | 100% | 979.88 | 459 / 459 | 99% | 57.42 | 1110 / 1118 |
| prostate | 100% | 1142.20 | 245 / 245 | 99% | 52.25 | 498 / 502 |
| kidney | 100% | 1210.73 | 89 / 89 | 99% | 39.68 | 893 / 901 |
| bladder | 100% | 981.33 | 21 / 21 | 99% | 82.55 | 499 / 504 |
| intestine | 100% | 1039.74 | 966 / 966 | 99% | 62.62 | 521 / 527 |
| pancreas | 100% | 561.78 | 327 / 328 | 99% | 58.85 | 176 / 178 |
| liver | 100% | 632.74 | 226 / 226 | 99% | 39.08 | 400 / 406 |
| lung | 99% | 894.20 | 573 / 578 | 99% | 69.05 | 1146 / 1155 |
| stomach | 100% | 884.78 | 359 / 359 | 98% | 44.21 | 280 / 286 |
| adipose | 100% | 914.54 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 80.51 | 29 / 29 |
| spleen | 100% | 1501.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 81.14 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 96.25 | 1 / 1 |
| blood vessel | 99% | 656.97 | 1327 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 44.94 | 79 / 80 |
| heart | 98% | 500.19 | 843 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 563.71 | 785 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 91% | 713.83 | 841 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043248 | Biological process | proteasome assembly |
| GO_0051131 | Biological process | chaperone-mediated protein complex assembly |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0044877 | Molecular function | protein-containing complex binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0060090 | Molecular function | molecular adaptor activity |
| Gene name | PSMG3 |
| Protein name | Proteasome assembly chaperone 3 (PAC-3) (hPAC3) |
| Synonyms | C7orf48 PAC3 |
| Description | FUNCTION: Chaperone protein which promotes assembly of the 20S proteasome. May cooperate with PSMG1-PSMG2 heterodimers to orchestrate the correct assembly of proteasomes. . |
| Accessions | Q9BT73 ENST00000404674.7 ENST00000252329.3 ENST00000288607.3 |